China National Accord Medicines Corporation Ltd. (SZSE:000028) agreed to acquire Sinopharm Guangdong Nanfang Foreign Trade Company from Sinopharm International Commerce and 11 private shareholders for approximately CNY 630 million on January 4, 2017. As per the terms of the transaction, 5.3 million shares will be issued as consideration for acquisition of 51% stake in Sinopharm Guangdong Nanfang Foreign Trade Company and CNY 273.6 million will be paid in cash for acquisition of 49% stake from 11 private shareholders. China National Accord Medicines Corporation Ltd. will issue locked price shares to Ping An Asset Management Co. Ltd. for total proceeds not exceeding CNY 273.6 million to be used for funding 100% of the price of the transaction to be paid in cash.